← Leaderboards
Elizabeth J. Shane
Mayo Clinic Rochester
$22,663,624
Attributed
$33,558,821
Total exposure
13
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,080,276 · 11
FDA$4,478,545 · 2
By mechanism
R01$30,328,683 · 8
K24$1,814,230 · 1
M01$771,962 · 3
U01$643,946 · 1
Top collaborators
- X. Edward Guo8 shared
- Dennis M Black4 shared
- Sundeep Khosla4 shared
- Clifford J Rosen4 shared
- Felix W Wehrli4 shared
- Adi Cohen3 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Sundeep Khosla$91,221,003
- Dennis M Black$9,656,727
- Shreyasee Amin$6,109,375
- Lichun Lu$5,236,018
- Jennifer J. Westendorf$18,995,005
Others in their field
Top investigators on “Osteoporosis”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,671,528
- Steven R Cummings · University Of California San Francisco$56,375,786
- Richard A Gibbs · Baylor College Of Medicine$49,965,365
- Peter J. Snyder · University Of Pennsylvania$36,531,878
- Douglas P. Kiel · Hebrew Rehabilitation Center For Aged$32,610,184
- Eric S. Orwoll · Oregon Health And Science University$28,146,073
Research focus
OsteoporosisBone DensityWomanFractureBiopsyPeripheralBoneBone StrengthOsteoblastsBone TurnoverBone LossPostmenopauseSkeletalX-Ray Computed TomographyMeasurementResolutionClinical ResearchBone RemodelingAffectMineralsRisk FactorsBone ResorptionHuman SubjectPathogenesis
Grant awards (68)
Subchondral Trabecular Plate and Rod Abnormalities in Human Osteoarthritis$624,380
R01 · FY2025 · AR
Beta1-selective blockade for prevention of postmenopausal bone loss: A randomized controlled trial$2,489,289
R01 · FY2024 · AG
Subchondral Trabecular Plate and Rod Abnormalities in Human Osteoarthritis$680,608
R01 · FY2024 · AR
Beta1-selective blockade for prevention of postmenopausal bone loss: A randomized controlled trial$2,456,365
R01 · FY2023 · AG
Subchondral Trabecular Plate and Rod Abnormalities in Human Osteoarthritis$725,294
R01 · FY2023 · AR
Beta1-selective blockade for prevention of postmenopausal bone loss: A randomized controlled trial$2,405,613
R01 · FY2022 · AG
Beta1-selective blockade for prevention of postmenopausal bone loss: A randomized controlled trial$2,347,808
R01 · FY2021 · AG
Teriparatide for Idiopathic Osteoporosis in Premenopausal Women: A Phase 2 Study$499,998
R01 · FY2019 · FD · contact PI
Phase 2b Study of Denosumab to Prevent Bone Loss in Idiopathic Osteoporosis in Premenopausal Women Treated with Teriparatide$414,452
R01 · FY2019 · FD · contact PI
Phase 2b Study of Denosumab to Prevent Bone Loss in Idiopathic Osteoporosis in Premenopausal Women Treated with Teriparatide$406,988
R01 · FY2018 · FD · contact PI
Teriparatide for Idiopathic Osteoporosis in Premenopausal Women: A Phase 2 Study$356,733
R01 · FY2018 · FD · contact PI
Phase 2b Study of Denosumab to Prevent Bone Loss in Idiopathic Osteoporosis in Premenopausal Women Treated with Teriparatide$403,667
R01 · FY2017 · FD · contact PI
Teriparatide for Idiopathic Osteoporosis in Premenopausal Women: A Phase 2 Study$400,681
R01 · FY2017 · FD · contact PI
Phase 2b Study of Denosumab to Prevent Bone Loss in Idiopathic Osteoporosis in Premenopausal Women Treated with Teriparatide$413,509
R01 · FY2016 · FD · contact PI
Phase 2 Teriparatide for Tx of Idiopathic Osteoporosis in Premenopausal Women$393,560
R01 · FY2015 · FD · contact PI
Osteoporosis in HIV Infected Postmenopausal Women$710,989
R01 · FY2014 · AI · contact PI
Clinical Bone Mechanics Using HR-pQCT$487,882
R01 · FY2014 · AR
Phase 2 Teriparatide for Tx of Idiopathic Osteoporosis in Premenopausal Women$397,791
R01 · FY2014 · FD · contact PI
Idiopathic Osteoporosis in Premenopausal Women$180,809
K24 · FY2014 · AR · contact PI
Osteoporosis in HIV Infected Postmenopausal Women$677,547
R01 · FY2013 · AI · contact PI
Clinical Bone Mechanics Using HR-pQCT$581,318
R01 · FY2013 · AR
Phase 2 Teriparatide for Tx of Idiopathic Osteoporosis in Premenopausal Women$196,150
R01 · FY2013 · FD · contact PI
Idiopathic Osteoporosis in Premenopausal Women$183,429
K24 · FY2013 · AR · contact PI
Osteoporosis in HIV Infected Postmenopausal Women$726,937
R01 · FY2012 · AI · contact PI
Clinical Bone Mechanics Using HR-pQCT and ??MRI$649,387
R01 · FY2012 · AR
Phase 2 Teriparatide for Tx of Idiopathic Osteoporosis in Premenopausal Women$196,764
R01 · FY2012 · FD · contact PI
Idiopathic Osteoporosis in Premenopausal Women$187,218
K24 · FY2012 · AR · contact PI
Phase 2 Teriparatide for Tx of Idiopathic Osteoporosis in Premenopausal Women$169,774
R01 · FY2012 · FD · contact PI
Osteoporosis in HIV Infected Postmenopausal Women$736,441
R01 · FY2011 · AI · contact PI
Clinical Bone Mechanics Using HR-pQCT and ??MRI$657,297
R01 · FY2011 · AR
Phase 2 Teriparatide for Tx of Idiopathic Osteoporosis in Premenopausal Women$228,478
R01 · FY2011 · FD · contact PI
Idiopathic Osteoporosis in Premenopausal Women$190,446
K24 · FY2011 · AR · contact PI
Osteoporosis in HIV Infected Postmenopausal Women$773,412
R01 · FY2010 · AI · contact PI
Clinical Bone Mechanics Using HR-pQCT and ??MRI$711,652
R01 · FY2010 · AR
Idiopathic Osteoporosis in Premenopausal Women$190,477
K24 · FY2010 · AR · contact PI
Ultra-high Resolution pQCT as a Biomarker of Bone Strength in Osteoporosis Trials$81,646
U01 · FY2010 · AR · contact PI
Osteoporosis in HIV-infected Postmenopausal Women$593,634
R01 · FY2009 · AI · contact PI
IDIOPATHIC OSTEOPOROSIS IN PREMENOPAUSAL WOMEN$575,889
R01 · FY2009 · AR · contact PI
Ultra-high Resolution pQCT as a Biomarker of Bone Strength in Osteoporosis Trials$186,747
U01 · FY2009 · AR · contact PI
Idiopathic Osteoporosis in Pre-menopausal Women$178,889
K24 · FY2009 · AR · contact PI
Osteoporosis in HIV-infected Postmenopausal Women$595,077
R01 · FY2008 · AI · contact PI
IDIOPATHIC OSTEOPOROSIS IN PREMENOPAUSAL WOMEN$558,956
R01 · FY2008 · AR · contact PI
Ultra-high Resolution pQCT as a Biomarker of Bone Strength in Osteoporosis Trials$186,747
U01 · FY2008 · AR · contact PI
Idiopathic Osteoporosis in Pre-menopausal Women$177,591
K24 · FY2008 · AR · contact PI
Osteoporosis in HIV-infected Postmenopausal Women$617,461
R01 · FY2007 · AI · contact PI
IDIOPATHIC OSTEOPOROSIS IN PREMENOPAUSAL WOMEN$571,049
R01 · FY2007 · AR · contact PI
Ultra-high Resolution pQCT as a Biomarker of Bone Strength in Osteoporosis Trials$188,806
U01 · FY2007 · AR · contact PI
Idiopathic Osteoporosis in Pre-menopausal Women$176,333
K24 · FY2007 · AR · contact PI
Osteoporosis in HIV-infected Postmenopausal Women$629,954
R01 · FY2006 · AI · contact PI
IDIOPATHIC OSTEOPOROSIS IN PREMENOPAUSAL WOMEN$596,633
R01 · FY2006 · AR · contact PI
Idiopathic Osteoporosis in Pre-menopausal Women$175,113
K24 · FY2006 · AR · contact PI
Osteoporosis in HIV-infected Postmenopausal Women$660,720
R01 · FY2005 · AI
IDIOPATHIC OSTEOPOROSIS IN PREMENOPAUSAL WOMEN$545,403
R01 · FY2005 · AR
Idiopathic Osteoporosis in Pre-menopausal Women$173,925
K24 · FY2005 · AR
ZOLEDRONIC ACID IN PROSTATE CANCER$322
M01 · FY2005 · RR
Prevention of Osteoporosis after Transplantation$397,434
R01 · FY2002 · AR
LOW BONE MASS IN YOUNG WOMEN$192,910
M01 · FY2002 · RR
BONE DISEASE AFTER CARDIAC TRANSPLANTATION$192,910
M01 · FY2002 · RR
PREVENTION OF OSTEOPOROSIS AFTER ORGAN TRANSPLANTATION$539,729
R01 · FY2001 · AR
LOW BONE MASS IN YOUNG WOMEN$192,910
M01 · FY2001 · RR
BONE DISEASE AFTER CARDIAC TRANSPLANTATION$192,910
M01 · FY2001 · RR
LOW BONE MASS IN YOUNG WOMEN$0
M01 · FY2001 · RR
BONE DISEASE AFTER CARDIAC TRANSPLANTATION$0
M01 · FY2001 · RR
PREVENTION OF OSTEOPOROSIS AFTER ORGAN TRANSPLANTATION$525,980
R01 · FY2000 · AR
BONE DISEASE AFTER CARDIAC TRANSPLANTATION$0
M01 · FY2000 · RR
LOW BONE MASS IN YOUNG WOMEN$0
M01 · FY2000 · RR
LOW BONE MASS IN YOUNG WOMEN$0
M01 · FY2000 · RR
BONE DISEASE AFTER CARDIAC TRANSPLANTATION$0
M01 · FY2000 · RR